Biotech one step closer to bowel disease treatment

Monday, August 22, 2016 - 12:04 in Health & Medicine

University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide. The company is headquartered in California with research operations at UQ’s Institute for Molecular Bioscience in Brisbane. It is working on the development of peptide-based oral drugs to treat inflammatory […]

Read the whole article on Science Blog

More from Science Blog

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net